Stem Cells: The Big Void of Toxicological Testing? – An Interview with James Sherley

Add bookmark
 Pharma IQ:     What have been the major advancements in using stem cells for toxicology testing?James Sherley:          I think the most recent advance, and probably the most well-known, is the production of induced pluripotent stem cells.  And the reason for that is that induced pluripotent stem cells give investigators the opportunity to develop many different types of tissues that are otherwise hard to get for toxicol...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended